A prospective, open label, single arm, historical control trial of tocilizumab with corticosteroids in patients with microscopic polyangiitis
Phase of Trial: Phase III
Latest Information Update: 23 Oct 2015
Price : $35 *
At a glance
- Drugs Tocilizumab (Primary) ; Corticosteroids
- Indications Microscopic polyangiitis
- Focus Therapeutic Use
- 19 Oct 2015 Status changed from recruiting to discontinued as reported by University Hospital Medical Information Network - Japan.
- 30 Oct 2014 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 04 Dec 2013 New trial record